Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Philippe Tangre"'
Autor:
Pierre Delobel, Adrien Saliou, Florence Nicot, Martine Dubois, Stéphanie Trancart, Philippe Tangre, Jean-Pierre Aboulker, Anne-Marie Taburet, Jean-Michel Molina, Patrice Massip, Bruno Marchou, Jacques Izopet, ANRS 106-Window Study Team
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21655 (2011)
The impact of minor drug-resistant variants of the type 1 immunodeficiency virus (HIV-1) on the failure of antiretroviral therapy remains unclear. We have evaluated the importance of detecting minor populations of viruses resistant to non-nucleoside
Externí odkaz:
https://doaj.org/article/e865aea80a9040a49e31605b234e3a7b
Autor:
Jean-Pierre Aboulker, Jacques Izopet, Isabelle Charreau, Jean-Michel Molina, Bruno Marchou, Window (Anrs ) Study Team, Karine Sauné, Philippe Tangre
Publikováno v:
Antiviral Therapy. 13:537-545
BackgroundWe aimed here to study drug-associated HIV resistance mutations in peripheral blood mononuclear cells (PBMC) and plasma during intermittent therapy.MethodsA substudy of 86 patients randomized to the intermittent treatment arm (8-week on/8-w
Autor:
Jean Dormont, Philippe Tangre, Jean Pierre Aboulker, Christine Tonéatti, Vincent Meiffrédy, Marine Harel, Véronique Eliette, Yacine Saidi
Publikováno v:
Contemporary Clinical Trials. 27:13-22
Objectives To assess the feasibility of coding with MedDRA, the Medical Dictionary for Regulatory Activities , not only serious adverse events required for notification but also all other events usually reported in HIV clinical trials. To develop an
Autor:
Muriel Bocquentin, Jean-Michel Molina, Jacques Izopet, Isabelle Charreau, Bruno Marchou, Philippe Tangre, Stéphanie Trancart, Anne-Marie Taburet, Jean-Pierre Aboulker
Efavirenz concentrations were measured in 21 patients during an interruption cycle of the ANRS 106 Window trial. The median efavirenz concentrations in the patients 12 h, 3 days, and 7 days after discontinuation of the drug were 1,962 ng/ml, 416 ng/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d349ee89261aa420cb75422e0a4e673
https://europepmc.org/articles/PMC3294880/
https://europepmc.org/articles/PMC3294880/
Autor:
Marie-Anne, Bouldouyre, Isabelle, Charreau, Bruno, Marchou, Philippe, Tangre, Christine, Katlama, Philippe, Morlat, Vincent, Meiffredy, Daniel, Vittecoq, Philippe, Bierling, Jean-Pierre, Aboulker, Jean-Michel, Molina, Merle, Pomies
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 52(5)
Incidence and risk factors for thrombocytopenia in patients discontinuing highly active antiretroviral therapy (HAART) have not been fully investigated.Well-suppressed patients on HAART were randomized to continuous (CT) or intermittent therapy (IT)
Autor:
Marine Saouzanet, Grégoire Jeanblanc, Laurence Boyer, Philippe Tangre, Isabelle Durand-Zaleski, Jean Pierre Aboulker, Bruno Marchou, Jean-Michel Molina, Isabelle Charreau
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 49(4)
Background: Structured treatment interruptions in chronic HIV infection have been explored as a drug-sparing strategy to reduce drug-related adverse events and costs while maintaining CD4 cell counts at a level high enough to prevent the risk of dise
Autor:
Jacques, Izopet, Bruno, Marchou, Isabelle, Charreau, Karine, Sauné, Philippe, Tangre, Jean-Michel, Molina, Jean-Pierre, Aboulker
Publikováno v:
Antiviral therapy. 13(4)
We aimed here to study drug-associated HIV resistance mutations in peripheral blood mononuclear cells (PBMC) and plasma during intermittent therapy.A substudy of 86 patients randomized to the intermittent treatment arm (8-week on/8-week off) of the A
Autor:
Bruno, Marchou, Philippe, Tangre, Isabelle, Charreau, Jacques, Izopet, Pierre-Marie, Girard, Thierry, May, Jean-Marie, Ragnaud, Jean-Pierre, Aboulker, Jean-Michel, Molina
Publikováno v:
AIDS (London, England). 21(4)
To assess the safety of a drug-sparing treatment regimen in patients with high CD4 cell counts and controlled HIV replication under antiretroviral therapy.An open-label, non-inferiority study involving 403 adults with CD4 cell counts of 450 x 10(6) c
Autor:
J.-M. Molina, Isabelle Fournier, M. Hanf, Fabienne Marcellin, Philippe Tangre, Jean-Pierre Aboulker, B. Marchou, Bruno Spire, Isabelle Charreau
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 56:71-72